Clinical Insights into the Neurodevelopmental Impact of 16p CNVs in an Italian Clinical Cohort
Genes · 2026
DOI: 10.3390/genes17020247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Ilaria La Monica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Chromosomes, Human, Pair 16, DNA Copy Number Variations, Neurodevelopmental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neurodevelopmental disorders (NDDs) are a heterogeneous group of conditions characterized by cognitive, behavioral, and developmental impairments, frequently linked to structural genomic alterations. Copy number variants (CNVs) involving chromosome 16, particularly the short arm 16p, are recognized contributors to neurodevelopmental variability. Despite increasing international evidence, data from Italian clinical cohorts are still limited.
Methods
We investigated 1200 patients referred for genetic evaluation due to suspected NDDs, including autism spectrum disorder (ASD), intellectual disability (ID), global developmental delay, and language impairment. All individuals underwent array comparative genomic hybridization (a-CGH) analysis, and identified variants were correlated with detailed clinical, cognitive, and behavioral assessments. The analysis focused on recurrent CNVs at 16p11.2, 16p13.3, and 16p13.11, regions containing dosage-sensitive genes relevant to neurodevelopment.
Results
CNVs involving the 16p region were identified in 96 patients (8% of the cohort), encompassing both deletions and duplications. Deletions were mainly associated with developmental delay, language deficits, and ASD-related features, whereas duplications were more frequently linked to behavioral dysregulation, attentional deficits, and variable cognitive impairment. Marked phenotypic variability was observed among individuals carrying similar CNVs, suggesting the contribution of modifying genetic or environmental factors. In a subset of patients, additional CNVs were identified, potentially exacerbating clinical severity, consistent with the two-hit model.
Conclusions
This study confirms a strong association between recurrent 16p CNVs and a wide spectrum of neurodevelopmental phenotypes in an Italian clinical cohort. The findings emphasize the diagnostic utility of systematic genomic screening and the importance of an integrated genotype–phenotype approach to improve clinical interpretation, management, and genetic counseling in NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.
- CEINGE-Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80145 Naples, Italy.
ORCID-Profile: Ilaria La Monica, Maria Rosaria Di Iorio, Lucio Pastore, Barbara Lombardo
Zitieren
APA
La Monica, I., Di Iorio, M. R., Sica, A., Pastore, L., & Lombardo, B. (2026). Clinical Insights into the Neurodevelopmental Impact of 16p CNVs in an Italian Clinical Cohort. Genes. https://doi.org/10.3390/genes17020247
Vancouver
La Monica I, Di Iorio MR, Sica A, Pastore L, Lombardo B. Clinical Insights into the Neurodevelopmental Impact of 16p CNVs in an Italian Clinical Cohort. Genes. 2026. doi:10.3390/genes17020247
BibTeX
@article{LaMonica2026,
author = {La Monica, Ilaria and Di Iorio, Maria Rosaria and Sica, Antonia and Pastore, Lucio and Lombardo, Barbara},
title = {Clinical Insights into the Neurodevelopmental Impact of 16p CNVs in an Italian Clinical Cohort},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020247}
}
EUVIMED